A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy

Blood

Volumn 88, Issue 12, 1996, Pages 4701-4710

  Bridges, K R ^a   Barabino, G D ^b   Brugnara, C ^b   Cho, M R ^b   Christoph, G W ^b   Dover, G ^b   Ewenstein, B M ^b   Golan, D E ^b   Guttmann, C R G ^b   Hofrichter, J ^b   Mulkern, R V ^b   Zhang, B ^b   Eaton, W A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN; HYDROXYUREA;

ANALYTIC METHOD; ARTICLE; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; MEAN CORPUSCULAR HEMOGLOBIN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; PRIORITY JOURNAL; RELAXATION TIME; RETICULOCYTE; SICKLE CELL;

EID: 10544232620     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4701.bloodjournal88124701     Document Type: Article

References (48)

1. Bunn HF, Forget BG: Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA, Saunders, p 453
2. Wethers DL: Problems and complications in the adolescent with sickle cell disease. Am J Pediatr Hematol Oncol 4:47, 1982
3. Kaul D, Fabry M, Windisch P, Baez S, Nagel R: Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest 72:22, 1983
4. Boyer S, Dover G, Serjeant G, Smith K, Antonarakis S, Embury S, Margolet L, Noyes A, Boyer M, Bias W: Production of F cells in sickle cell anemia: Regulation by a genetic locus or loci separate from the beta-globin gene cluster. Blood 64:1053, 1984
5. el-Hazmi M, Bahakim H, Warsy A: DNA polymorphism in the beta-globin gene cluster in Saudi Arabs: Relation to severity of sickle cell anaemia. Acta Haematol 88:61, 1992
6. Miller B, Olivieri N, Salameh M, Ahmed M, Antognetti G, Huisman T, Nathan D, Orkin S: Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med 316:244, 1987
7. Singer K, Singer L: The gelling phenomenon of sickle hemoglobin: Its biological and diagnostic significance. Blood 8:1008, 1953
8. Bookchin R, Ortiz O, Lew V: Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 87:113, 1991
9. Eaton W, Hofrichter J: The biophysics of sickle cell hydroxyurea therapy. Science 268:1142, 1995
10. Eaton W, Hofrichter J: Hemoglobin S gelation and sickle cell disease. Blood 70:1245, 1987
11. Goldberg M, Husson M, Bunn H: The participation of hemoglobins A and F in the polymerization of sickle hemoglobin. J Biol Chem 252:3414, 1977
12. Platt O, Orkin S, Dover G, Beardsley G, Miller B, Nathan D: Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 74:652, 1984
13. Rodgers G, Dover G, Noguchi C, Schechter A, Nienhuis A: Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 322:1037, 1990
14. Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G: Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N Engl J Med 313:1571, 1985
15. Goldberg M, Dover D, Schapira L, Charache S, Bunn H: Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 323:366, 1990
16. Dover G, Humphries R, Moore J, Ley T, Young N, Charache S, Nienhuis A: Hydroxyurea induction of hemoglobin F production in sickle cell disease: Relationship between cytotoxicity and F cell production. Blood 67:735, 1986
17. Charache S, Dover G, Moore R, Eckert S, Ballas S, Koshy M, PF M, Orringer E, Phillips GJ, Platt O, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
18. Goldberg M, Brugnara C, Dover G, Schapira L, Lacroix L, Bunn H: Hydroxyurea and erythropoietin therapy in sickle cell anemia. Semin Oncol 19:74, 1992
19. Charache S: Hydroxyurea as treatment for sickle cell anemia. Hematol Oncol Clin North Am 5:571, 1991
20. Charache S, Terrin M, Moore R, Dover G, Barton F, Eckert S, McMahon R, Bonds D: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332:1317, 1995
21. Dover G, Boyer S, Charache S, Heintzelman K: Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 299:1428, 1978
22. Gimbrone M: Culture of vascular endothelium. Prog Hemost Thromb 3:1, 1976
23. Barabino G, Mclntire L, Eskin S, Sears D, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
24. Mulkern RV, Bower JL, Heff A, Guttmann CRG, Sadowski RH. Triexponential decomposition of 1H spin-lattice relaxation decay curves of paramagnetically doped red cell suspensions at 7T. Phys Med Biol 41:255, 1996
25. Herbst MD, Goldstein JH: A review of water diffusion measurement by NMR in human red blood cells. Am J Physiol 256:C1097, 1989
26. Guttmann CRG, Bridges KR, Brugnara C, Dover GJ, Mulkern RV: Hydroxyurea treatment of sickle cell patients significantly alters red cell T2 relaxation times. Proc Soc Magn Reson 3:1360, 1994
27. Brugnara C, Hipp MJ, Irving PJ, Lathrop H, Lee PA, Minchello EM, Winkelman J: Automated reticulocyte counting and measurement of reticulocyte cellular indices: Evaluation of the Miles H*3 blood analyzer. Am J Clin Pathol 102:623, 1994
28. Brugnara C, Tosteson D: Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 70:1810, 1987
29. + channel: The imidazole ring is not required for inhibitory activity. J Pharmacol Exp Ther 273:266, 1995
30. Corbett JD, Golan DE: Band 3 and glycophorin are progressively aggregated in density fractionated sickle and normal red blood cells: Evidence from rotational and lateral mobility studies. J Clin Invest 91:208, 1993
31. Corash L, Shafer B, Perlow M: Heterogeneity of human whole blood platelet subpopulations. II. Use of a subhuman primate model to analyse the relationship between density and platelet age. Blood 52:726, 1978
32. Galili U, Clark MR, Shohet SB: Excessive binding of natural anti-alpha-galactosyl immunoglobulin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 77:27, 1986
33. Coletta M, Hofrichter J, Ferrone F, Eaton W: Kinetics of sickle hemoglobin polymerization in single red cells. Nature 300:194, 1982
34. Mozzarelli A, Hofrichter J, Eaton W: Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 237:500, 1987
35. Ferrone F, Hofrichter J, Eaton W: Kinetics of sickle hemoglobin polymerization 1. Studies using temperature-jump and laser photolysis techniques. J Mol Biol 183:591, 1985
36. Smith B, La Celle P: Erythrocyte-endothelial cell adherence in sickle cell disorders. Blood 68:1050, 1986
37. Mohandas N, Evans E: Adherence of sickle erythrocytes to vascular endothelial cells: Requirement for both cell membrane changes and plasma factors. Blood 64:282, 1984
38. 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:3548, 1993
39. Adragna NC, Fonseca P, Lauf PK: Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesions in cultured vascular endothelial cells. Blood 83:553, 1994
40. 2 and temperature control. Blood 79:2141, 1992
41. Kuross S, Rank B, Hebbel R: Excess heme in sickle erythrocyte inside-out membranes: Possible role in thiol oxidation. Blood 71:876, 1988
42. Fabry M, Romero J, Buchanan I, Suzuka S, Stamatoyannopoulos G, Nagel R, Canessa M: Rapid increase in red blood cell density driven by K:C1 cotransport in a subset of sickle cell anemia reticulocytes and discocytes. Blood 78:217, 1991
43. Milner P, Garbutt G, Nolan-Davis L, Jonah F, Wilson L, Wilson J: The effect of HbF and alpha-thalassemia on the red cell indices in sickle cell anemia. Am J Hematol 21:383, 1986
44. Sunshine H, Hofrichter J, Eaton W: Requirements for therapeutic inhibition of sickle hemoglobin gelation. Nature 275:238-240, 1978
45. San Biagio P, Hofrichter J, Mozzarelli A, Henry E, Eaton W: Current perspectives on the kinetics of hemoglobin S gelation. Ann N Y Acad Sci 565:53, 1989
46. Eaton W, Hofrichter J: Sickle cell hemoglobin polymerization. Adv Prot Chem 40:63, 1990
47. Hofrichter J, Ross P, Eaton W: Kinetics and mechanism of deoxyhemoglobin S gelation. A new approach to understanding sickle cell disease. Proc Natl Acad Sci USA 71:4864, 1974
48. Eaton W, Hofrichter J, Ross P: Delay time of gelation: A possible determinant of clinical severity in sickle cell disease. Blood 47:621, 1976